Delivery Order SPE2DR25D1109-SPE2DR26FFL0B
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,137.68 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count units) under a firm fixed-price contract. The award, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, represents a competitive procurement with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Nucynta ER 100 mg tablets (60-count packaging) with a ceiling value of $2,105.08. This firm fixed-price, competitively awarded delivery order is scheduled for completion by January 20, 2026, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,319.78 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count) on January 5, 2026, with completion scheduled for January 6, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,941.77 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 200 mg tablets (60-count units) on August 29, 2025, with a completion date of September 2, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $4,416.12 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count packages) on August 20, 2025, with a completion date of August 21, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units) with a ceiling value of $6,598.58 and an ultimate completion date of December 1, 2025. This is a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,205.75 firm fixed-price delivery order by the Defense Logistics Agency on June 2, 2025, for Nucynta ER 200 mg tablets (60-count supply). The contract, which carries an ultimate completion date of June 3, 2025, represents a non-competitive award and serves the federal medical supply chain supporting military and veteran healthcare systems. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 25, 2025, for the supply of Nucynta ER Tablets 100mg with a ceiling value of $12,560.28. The competitively awarded, firm fixed-price delivery order is funded by the Defense Department's Medical Supply Chain and is due for completion by November 26, 2025. This award represents a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,334.68 delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Nucynta ER 200 mg tablets (60-count units). This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $1 billion through December 2026. The award utilized firm fixed pricing with no set-aside designation, reflecting competitive procurement through open competition....
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $9,338.00 to AmerisourceBergen Drug Corp for the supply of Nucynta ER Tabs 200mg, a pain management pharmaceutical. The contract is a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. The order was awarded on January 6, 2026, with an ultimate completion date of January 7, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania....
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFL0BDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Nucynta ER 100 mg tablets (60-count units) at a firm fixed price of $1,468.04, with completion scheduled for January 21, 2026. This competitively awarded, non-set-aside contract represents a task order execution under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion vehicle valued through December 2026 that serves as the primary pharmaceutical supply mechanism for military healthcare systems globally. The parent company, Cencora, Inc., operates under the AmerisourceBergen business name and maintains an even larger IDC with DLA valued at up to $999.999 billion through December 31, 2031, positioning the company as a critical vendor for federal medical procurement across therapeutic domains including pain management, specialty medications, and generic pharmaceuticals. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen demonstrates significant federal contracting capacity through its comprehensive portfolio of medical product deliveries to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm fixed-price delivery order structure is consistent with AmerisourceBergen's typical federal contracting approach, which encompasses transactions ranging from minimal orders to substantial purchases exceeding $45,000. This award exemplifies the company's role in supporting military healthcare logistics and reflects the pharmaceutical supply chain's reliance on established prime vendors to deliver critical medications efficiently to federal medical facilities and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 1/19/26 |